日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Gemcitabine Intravesical System Plus Cetrelimab or Cetrelimab Alone as Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer: SunRISe-4 Primary Analysis and Biomarker Results

吉西他滨膀胱灌注系统联合西曲利单抗或单用西曲利单抗作为肌层浸润性膀胱癌新辅助治疗：SunRISe-4 主要分析和生物标志物结果

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-02382
Necchi, Andrea; Guerrero-Ramos, Félix; Crispen, Paul L; Herrera-Imbroda, Bernardo; Garje, Rohan; Szabados, Bernadett; Peyton, Charles C; Pradere, Benjamin; Ku, Ja Hyeon; Shore, Neal; Bögemann, Martin; Preston, Mark A; Xylinas, Evanguelos; Sanchez de Llano, Cristina; Gong, Cinty; Hasan, Mohamad; Urtishak, Karen; Battaglia, Sebastiano; Stitou, Hind; Bhanvadia, Sumeet; Sweiti, Hussein; Psutka, Sarah P
肿瘤
肿瘤免疫
膀胱癌
发表日期：2026
文献求助 收藏

Erdafitinib in Patients with FGFR-Altered Advanced or Metastatic Cholangiocarcinoma

Erdafitinib治疗FGFR改变的晚期或转移性胆管癌患者

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-2264
Pant, Shubham; Park, Joon Oh; Su, Wu-Chou; Loriot, Yohann; Carranza, Omar; Corassa, Marcelo; Doi, Toshihiko; Qin, Shukui; Tabernero, Josep; Prenen, Hans; Folprecht, Gunnar; Winter, Helen; Dal Molin, Graziela Z; Shen, Lin; Qian, Jiaqi; Liao, Huimin; Thomas, Shibu; Sweiti, Hussein; Triantos, Spyros; Feng, Yin-Hsun
肿瘤
胆管癌
肿瘤免疫
发表日期：2026
文献求助 收藏

Side effect management and procedural best practices with indwelling intravesical drug-releasing systems in the treatment of bladder cancer: recommendations from expert panels

膀胱癌治疗中留置膀胱内药物释放系统的副作用管理和操作最佳实践：专家组建议

期刊:Current Opinion in Urology
影响因子:2.2
doi:10.1097/MOU.0000000000001350
Pradere, Benjamin; Schuit, Maarten; Guerrero-Ramos, Félix; Shariat, Shahrokh F; Kitamura, Hiroshi; Jacob, Joseph M; Bao, Yige; Heesakkers, John; Peters, Kenneth M; Cahn, David J; De Troyer, Bart; Herrera Imbroda, Bernardo; Morris, David S; Pieczonka, Christopher M; Wei, Qiang; Bhanvadia, Sumeet; Somer, Robert; Jessner, Wolfgang; Triantos, Spyros; Sánchez de Llano, Cristina; Maffeo, John C; Sweiti, Hussein; Psutka, Sarah P
肿瘤
肿瘤免疫
膀胱癌
发表日期：2026
文献求助 收藏

TAR-200 for Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study

TAR-200 用于卡介苗治疗无效的高危非肌层浸润性膀胱癌：来自 IIb 期 SunRISe-1 研究的结果

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-01651
Daneshmand, Siamak; Van der Heijden, Michiel S; Jacob, Joseph M; Guerrero-Ramos, Felix; Bögemann, Martin; Simone, Giuseppe; Pieczonka, Christopher M; Casco, Nelson Canales; Zainfeld, Daniel; Spiegelhalder, Philipp; Xylinas, Evanguelos; Cahn, David; Lotan, Yair; Murray, Katie S; Kawahara, Takashi; Stromberg, Katharine; Martin, Jason; Shukla, Abhijit; Cutie, Christopher J; Bertzos, Kristi; Hampras, Shalaka; Sweiti, Hussein; Necchi, Andrea
肿瘤
肿瘤免疫
膀胱癌
发表日期：2025
文献求助 收藏

Prognostic Impact of Oncogenic Fibroblast Growth Factor Receptor Alterations in Patients With Advanced Solid Tumors in a Real-World Setting

真实世界中致癌成纤维细胞生长因子受体改变对晚期实体瘤患者预后的影响

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.70546
Demirdjian, Levon; Triantos, Spyros; Standish, Kristopher; Thomas, Shibu; Xia, Qi; Zhang, Jiarui; Greshock, Joel; Paone, Julie; Sheridan, Paige; Pant, Shubham; Massard, Christophe; Reardon, David A; Loriot, Yohann; Schuler, Martin; Sweiti, Hussein
成纤维细胞
肿瘤
肿瘤免疫
信号转导
细胞生物学
发表日期：2025
文献求助 收藏

Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial

Erdafitinib治疗亚洲晚期实体瘤患者：一项开放标签、单臂IIa期试验

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-024-12584-0
Park, Joon Oh; Feng, Yin-Hsun; Su, Wu-Chou; Oh, Do-Youn; Keam, Bhumsuk; Shen, Lin; Kim, Sang-We; Liu, Xiufeng; Liao, Huimin; Qing, Min; Zhang, Chong; Qian, Jiaqi; Tang, Xiaodan; Li, Peng; Triantos, Spyros; Sweiti, Hussein
发表日期：2024
文献求助 收藏

Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study

Erdafitinib治疗伴有FGFR改变的晚期实体瘤患者（RAGNAR）：一项国际性、单臂、II期研究

期刊:Lancet Oncology
影响因子:35.9
doi:10.1016/S1470-2045(23)00275-9
Pant, Shubham; Schuler, Martin; Iyer, Gopa; Witt, Olaf; Doi, Toshihiko; Qin, Shukui; Tabernero, Josep; Reardon, David A; Massard, Christophe; Minchom, Anna; Lugowska, Iwona; Carranza, Omar; Arnold, Dirk; Gutierrez, Martin; Winter, Helen; Stuyckens, Kim; Crow, Lauren; Najmi, Saltanat; Hammond, Constance; Thomas, Shibu; Santiago-Walker, Ademi; Triantos, Spyros; Sweiti, Hussein; Loriot, Yohann
发表日期：2023
文献求助 收藏

Adherence Measures for Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate plus Prednisone: Results of a Prospective, Cluster-Randomized Trial

接受醋酸阿比特龙联合泼尼松治疗的转移性去势抵抗性前列腺癌患者的依从性措施：一项前瞻性、整群随机试验的结果

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers12092550
Suttmann, Henrik; Gleissner, Jochen; Huebner, Andreas; Mathes, Tim; Baurecht, Werner; Krützfeldt, Katrin; Sweiti, Hussein; Feyerabend, Susan
肿瘤
前列腺癌
肿瘤免疫
发表日期：2020
文献求助 收藏

Repurposed Therapeutic Agents Targeting the Ebola Virus: A Systematic Review

针对埃博拉病毒的再利用治疗药物：系统性综述

期刊:Current Therapeutic Research-Clinical and Experimental
影响因子:1.5
doi:10.1016/j.curtheres.2017.01.007
Sweiti, Hussein; Ekwunife, Obinna; Jaschinski, Thomas; Lhachimi, Stefan K
微生物学
发表日期：2017
文献求助 收藏

Repurposed therapeutic agents targeting the Ebola virus: a protocol for a systematic review

针对埃博拉病毒的再利用治疗药物：系统评价方案

期刊:Systematic Reviews
影响因子:3.9
doi:10.1186/s13643-015-0153-9
Sweiti, Hussein; Ekwunife, Obinna; Jaschinski, Thomas; Lhachimi, Stefan K
微生物学
发表日期：2015
文献求助 收藏